Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer

NCT04195828 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Camrelizumab
DRUG: Apatinib Mesylate
DRUG: nab-paclitaxel
DRUG: S1

Sponsor

Fujian Medical University